It's good we have reached the stage where CZM is actively promoting and demonstrating CONVIVO along its KINEVO product.
What bothers me with OIL's FY18 financials is the administration and R&D expense lines. They eat up all of the cash generated by revenue and yet it's hard to see what kind of return these expenses bring.
How much more R&D is required?
How come OIL is spending that much money on marketing? Carl Zeiss has already dedicated 60 sales staff to promote and sell the microscopes! I take it that marketing spend may relate to ViewnVivo, but we haven't seen much return judging by slow sales.
I'd like to see the costs reduced substantially in FY19. I expect the management to preserve cash, stop asking shareholders for more money and work out a decent strategy around ViewnVivo!
- Forums
- ASX - By Stock
- Ann: Appendix 4E and 2018 Annual Report
It's good we have reached the stage where CZM is actively...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
|
|||||
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $158.7M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 19.0¢ | $10.58K | 55.71K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31205 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 50018 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31205 | 0.190 |
1 | 55500 | 0.185 |
2 | 57139 | 0.180 |
2 | 13000 | 0.175 |
2 | 30735 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 50000 | 1 |
0.200 | 34925 | 2 |
0.205 | 100000 | 1 |
0.210 | 22129 | 3 |
0.215 | 87500 | 3 |
Last trade - 15.59pm 23/08/2024 (20 minute delay) ? |
OIL (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online